Isolated pulmonary valve infective endocarditis in a middle aged man caused by Candida albicans: a case report

BMC Infectious Diseases

Saumil Doshi¹  Bryan Curry²  Sudhakar Devathi¹ 

[1] Division of Infectious Diseases, Howard University College of Medicine, Washington, DC, USA;Division of Cardiology, Howard University College of Medicine, Washington, DC, USA

关键词: Fungal endocarditis;    Candida albicans;    Pulmonary valve;   

Others  :  1122150
DOI  :  10.1186/s12879-014-0557-5

 received in 2014-06-19, accepted in 2014-10-10,  发布年份 2014

【 摘 要 】

Background

Pulmonary valve endocarditis without the involvement of other valves represents 1.5-2% of all cases of infective endocarditis. Isolated pulmonary valve endocarditis caused by Candida is extremely rare with only one reported case in the literature and none reported in the United States. Guidelines for management of Candida endocarditis recommend a combination of medical and surgical therapy.

Case presentation

A 61-year-old homeless male presented with fever, cough and shortness of breath. He was urgently intubated for hypoxia. He was initially diagnosed with pneumonia but did not improve with empiric antibacterial therapy. Candida species were isolated from bronchoalveolar lavage fluid and the patient eventually developed persistent C. albicans bloodstream infection. On further workup he was found to have infective endocarditis with a large vegetation across the pulmonary valve. No other valves were involved. He was treated with intravenous antifungal therapy for eight weeks. Valvular surgery was not performed. Follow up echocardiography after completion of therapy did not show any vegetations and the patient clinically improved.

Conclusion

This is the second reported case of isolated pulmonary valve endocarditis caused by Candida and the first to be successfully managed with antifungal therapy alone. Pulmonary valve endocarditis should be considered in cases of pneumonia with Candida and persistent fungemia. While surgery should be considered in all cases of Candida endocarditis, cure may be achieved with antifungal therapy alone.

【 授权许可】

   
2014 Devathi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Deng H, Ma Y, Zhai H, Miao Q: Surgical valve repair of isolated pulmonary valve endocarditis. Interact Cardiovasc Thorac Surg 2013, 16:384-386.
• [2]Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W: Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 2001, 32:50-62.
• [3]Baddley JW, Pappas PG: Antifungal combination therapy: clinical potential. Drugs 2005, 65:1461-1480.
• [4]Baddley JW, Benjamin DK Jr, Patel M, Miro J, Athan E, Barsic B: Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 2008, 27:519-529.
• [5]Lefort A, Chartier L, Sendid B: Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect 2012, 18(4):E99-E109.
• [6]Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD: Infectious diseases society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis 2009, 48(5):503-535.
• [7]Uchida W, Hirate Y, Ito H, Kawaguchi O: Two-stage operation for isolated pulmonary valve infections endocarditis with Candida parapsilosis. Interact Cardiovasc Thorac Surg 2013, 17(2):426-427.
• [8]Gonzalez-Juanatey C, Testa-Fernandez A, Lopez-Alvarez M: Isolated pulmonary native valve infectious endocarditis due to Enterococcus faecalis. Int J Cardiol 2006, 113:E19-E20.
• [9]Frontera JA, Gradon JD: Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000, 30:374-379.
• [10]Tekin R, Acet H, Ertas F: An unusual case of endocarditis: isolated pulmonary valve endocarditis in patient with patent ductus arteriosus. J Med Cases 2012, 3(6):340-343.
• [11]William F, Armstrong MD, Thomas Ryan MD: Feigenbaums’s Echocardiography. 2009.
• [12]Vaideeswar P, Jawale RM, Tullu M: Isolated infective endocarditis of the pulmonary valve: an autopsy analysis of nine cases. Cardiovasc Pathol 2009, 18(4):231-235.
• [13]Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP: Primary Candida pneumonia.Experience at a large cancer center and review of the literature. Medicine 1993, 72:137-142.
• [14]Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA: Infective endocarditis: diagnosis, antimicrobial therapy and management of complications: a statement from the committee on rheumatic fever, endocarditis and Kawasaki disease. Circulation 2005, 111:e394-e434.
• [15]Steinbach , Perfect JR, Cabell CH, Fowler VG, Corey GR, Li JS, Zaas AK, Benjamin DK Jr: A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 2005, 51(3):230-247.
• [16]Talarmin JP, Boutoille D, Tattevin P, Abgueguen P, Ansart S, Roblot F, Raffi F: Candida endocarditis: role of new antifungal agents. Mycoses 2009, 52(1):60-66.
• [17]Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA: Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemotherapy 2002, 46(6):1773-1780.
• [18]Pai MP: Antifungal combinations against simulated Candida albicans endocardial vegetations. Antimicrob Agents Chemother 2009, 53(6):2629-2631.